Capital Research Global Investors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $85M | Sell |
|
|||||
2025
Q1 | $100M | Sell |
|
|||||
2024
Q4 | $331M | Sell |
|
|||||
2024
Q3 | $357M | Sell |
|
|||||
2024
Q2 | $572M | Buy |
|
|||||
2024
Q1 | $570M | Buy |
|
|||||
2023
Q4 | $558M | Sell |
|
|||||
2023
Q3 | $593M | Sell |
|
|||||
2023
Q2 | $570M | Buy |
|
|||||
2023
Q1 | $551M | Buy |
|
|||||
2022
Q4 | $468M | Sell |
|
|||||
2022
Q3 | $465M | Buy |
|
|||||
2022
Q2 | $409M | Buy |
|
|||||
2022
Q1 | $345M | Buy |
|
|||||
2021
Q4 | $109M | Buy |
|
|||||
2021
Q3 | $80M | Sell |
|
|||||
2021
Q2 | $179M | Sell |
|
|||||
2021
Q1 | $690M | Buy |
|
|||||
2020
Q4 | $669M | Buy |
|
|||||
2020
Q3 | $421M | Buy |
|
|||||
2020
Q2 | $357M | Buy |
|
|||||
2020
Q1 | $288M | Buy |
|
|||||
2019
Q4 | $310M | Buy |
|
|||||
2019
Q3 | $322M | Hold |
|
|||||
2019
Q2 | $307M | Buy |
|
|||||
2019
Q1 | $124M | Hold |
|
|||||
2018
Q4 | $141M | Sell |
|
|||||
2018
Q3 | $186M | Hold |
|
|||||
2018
Q2 | $146M | Buy |
|
|||||
2018
Q1 | $89.5M | Buy |
|
|||||
2017
Q4 | $20.5M | Buy |
|